NLRP3 inflammasome as a novel therapeutic target for heart failure
Heart failure (HF) is a leading cause of mortality worldwide. The pathogenesis of HF is complex and has not yet been fully elucidated, which has slowed drug development and long-term treatments. Inflammasome-mediated responses occur during the progression of HF. It has been reported that energy meta...
Main Authors: | Shuangcui Wang, Jiaqi Zhang, Yuli Wang, Xijuan Jiang, Maojuan Guo, Zhen Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2022-01-01
|
Series: | Anatolian Journal of Cardiology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-13103 |
Similar Items
-
NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
by: Yucheng Wang, et al.
Published: (2020-03-01) -
Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
by: Yingdong Lu, et al.
Published: (2022-06-01) -
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
by: Allison K. Meyers, et al.
Published: (2020-07-01) -
NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021-04-01) -
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
by: Tao Liang, et al.
Published: (2022-02-01)